| 000 | a | ||
|---|---|---|---|
| 999 |
_c16256 _d16256 |
||
| 003 | OSt | ||
| 005 | 20220208113052.0 | ||
| 008 | 220208b xxu||||| |||| 00| 0 eng d | ||
| 040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
| 100 |
_915916 _aKotha, Anusha |
||
| 245 | _aDithiocarbamate substituted phenothiazine derivatives: in silicoexperiments, synthesis,and biological evaluation | ||
| 250 | _aVol.13(10) | ||
| 260 |
_aM P _bInnovare Academic Sciences Pvt Ltd _c2021 |
||
| 300 | _a25-30p. | ||
| 520 | _aObjective: The present study was designed to study the anticancer activity of a series of novel analogs of phenothiazine with dithiocarbamate as a side chain.Methods: A novel series of derivatives containing dithiocarbamate as a side chain at the tenth position of phenothiazine nucleus were synthesized, characterized by spectral analysis, and evaluated for their antimitotic and antioxidant activity using germinated Bengal gram seeds and 2,2-diphenyl-1-picrylhydrazyl (DPPH)method,respectively. A quantitative estimate of drug-likeness was also performed,which calculated the molecular properties and screenedthe molecules based on drug-likeness rules.Further, molecular docking study was performed for finding the binding affinity with tubulin protein to rationalize their anticancer activity.Results: The results revealed that the antioxidant activity of compounds3e, 3g, 3i, 3j andstandard Ascorbic acid were 10 mmol, 14 mmol, 16 mmol, 16 mmoland 35 mmol,respectively. Further compounds 3e, 3g, 3h and 3i have shown promising antimitotic activity. Compound 3i (-9 K. Cal/mol) showed the highest binding energies towards tubulin protein when compared to standard drug colchicine (-8.6 K. Cal/mol). Among all, compound 3i showed promising antimitoticand antioxidant activity, which correlated with insilico docking studies.Conclusion: Dithiocarbamate substituted phenothiazine derivatives proved to be encouraging leads as tubulin inhibitors. | ||
| 650 | 0 |
_94639 _aPHARMACEUTICS |
|
| 700 |
_915917 _a Muni Sireesha, S. |
||
| 773 | 0 |
_tInternational journal of pharmacy and pharmaceutical science _dBhopal Innovare Academic Sciences Pvt Ltd _x2656-0097 |
|
| 856 |
_uhttps://innovareacademics.in/journals/index.php/ijpps/article/view/41882/25491 _yClick here |
||
| 942 |
_2ddc _cAR |
||